Bentoquatam: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Bentoquatam": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(One intermediate revision by one other user not shown)
Line 24: Line 24:
*Shake well before use
*Shake well before use
*apply 15 minutes before risk exposure
*apply 15 minutes before risk exposure
*avoid intentional contact with poison ivy, oak and sumac
*avoid intentional contact with [[poison ivy]], oak and [[sumac]]
*adults and children 6 and older:  apply every 4 hours for continued protection or sooner if needed
*adults and children 6 and older:  apply every 4 hours for continued protection or sooner if needed
*children under 6 years:  ask a doctor
*children under 6 years:  ask a doctor
Line 51: Line 51:


<!--Contraindications-->
<!--Contraindications-->
|contraindications=*[[hypersensitivity]] to bentoquatam and any components of the products such as [[methylparabens]]
|contraindications=*[[Hypersensitivity]] to bentoquatam and any components of the products such as [[methylparabens]]




Line 85: Line 85:
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with [[renal impairment]].
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with [[hepatic impairment]].
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are [[immunocompromised]].


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->

Latest revision as of 18:00, 18 August 2015

Bentoquatam
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Bentoquatam is a Protectant, Dermatological that is FDA approved for the prevention of poison ivy, oak and sumac rash when applied before exposure. Common adverse reactions include erythema.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

  • Helps prevent poison ivy, oak and sumac rash when applied before exposure.
Dosage
Directions
  • Shake well before use
  • apply 15 minutes before risk exposure
  • avoid intentional contact with poison ivy, oak and sumac
  • adults and children 6 and older: apply every 4 hours for continued protection or sooner if needed
  • children under 6 years: ask a doctor
  • remove with soap and water after risk of exposure

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Bentoquatam in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Bentoquatam in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Bentoquatam in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Bentoquatam in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Bentoquatam in pediatric patients.

Contraindications

Warnings

  • For external use only. Flammable: keep away from fire or flame.
  • Do not use: if you are allergic to any ingredients, on open rash. When using this product: do not get into eyes. If contact occurs, rinse eyes thoroughly with water.
  • Keep out of reach of children.
  • If swallowed, get medical help or contact a Poison Control Center right away.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Bentoquatam in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Bentoquatam in the drug label.

Drug Interactions

There is limited information regarding Bentoquatam Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Bentoquatam in women who are pregnant.
Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Bentoquatam in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Bentoquatam during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Bentoquatam with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Bentoquatam with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Bentoquatam with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Bentoquatam with respect to specific gender populations.

Race

There is no FDA guidance on the use of Bentoquatam with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Bentoquatam in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Bentoquatam in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Bentoquatam in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Bentoquatam in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Topical Lotion

Monitoring

There is limited information regarding Monitoring of Bentoquatam in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Bentoquatam in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Bentoquatam in the drug label.

Pharmacology

There is limited information regarding Bentoquatam Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Bentoquatam Mechanism of Action in the drug label.

Structure

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Bentoquatam in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Bentoquatam in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Bentoquatam in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Bentoquatam in the drug label.

How Supplied

There is limited information regarding Bentoquatam How Supplied in the drug label.

Storage

There is limited information regarding Bentoquatam Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Bentoquatam |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Bentoquatam |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Bentoquatam in the drug label.

Precautions with Alcohol

  • Alcohol-Bentoquatam interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Bentoquatam Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Bentoquatam Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

{{#subobject: 

 |Page Name=Bentoquatam
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}


{{#subobject: 

 |Label Page=Bentoquatam
 |Label Name=b01.png

}}


{{#subobject: 

 |Label Page=Bentoquatam
 |Label Name=b02.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Bentoquatam&oldid=1134788"